These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10546893)

  • 1. SUMO/sentrin: protein modifiers regulating important cellular functions.
    Kretz-Remy C; Tanguay RM
    Biochem Cell Biol; 1999; 77(4):299-309. PubMed ID: 10546893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
    Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
    Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2.
    Saitoh H; Sparrow DB; Shiomi T; Pu RT; Nishimoto T; Mohun TJ; Dasso M
    Curr Biol; 1998 Jan; 8(2):121-4. PubMed ID: 9427648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1.
    Bernier-Villamor V; Sampson DA; Matunis MJ; Lima CD
    Cell; 2002 Feb; 108(3):345-56. PubMed ID: 11853669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1.
    Desterro JM; Rodriguez MS; Kemp GD; Hay RT
    J Biol Chem; 1999 Apr; 274(15):10618-24. PubMed ID: 10187858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9.
    Gong L; Kamitani T; Fujise K; Caskey LS; Yeh ET
    J Biol Chem; 1997 Nov; 272(45):28198-201. PubMed ID: 9353268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of Ran GTPase-activating protein by the small ubiquitin-related modifier SUMO-1 requires Ubc9, an E2-type ubiquitin-conjugating enzyme homologue.
    Lee GW; Melchior F; Matunis MJ; Mahajan R; Tian Q; Anderson P
    J Biol Chem; 1998 Mar; 273(11):6503-7. PubMed ID: 9497385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUMO modification through rapamycin-mediated heterodimerization reveals a dual role for Ubc9 in targeting RanGAP1 to nuclear pore complexes.
    Zhu S; Zhang H; Matunis MJ
    Exp Cell Res; 2006 Apr; 312(7):1042-9. PubMed ID: 16469311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin-related modifier SUMO1 and nucleocytoplasmic transport.
    Pichler A; Melchior F
    Traffic; 2002 Jun; 3(6):381-7. PubMed ID: 12010456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMO wrestling with specificity.
    VanDemark AP; Hill CP
    Structure; 2002 Mar; 10(3):281-2. PubMed ID: 12005425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of NF-kappa B transcriptional activation by signal induced proteolysis of I kappa B alpha.
    Hay RT; Vuillard L; Desterro JM; Rodriguez MS
    Philos Trans R Soc Lond B Biol Sci; 1999 Sep; 354(1389):1601-9. PubMed ID: 10582246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2.
    Okuma T; Honda R; Ichikawa G; Tsumagari N; Yasuda H
    Biochem Biophys Res Commun; 1999 Jan; 254(3):693-8. PubMed ID: 9920803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular targeting of proteins by sumoylation.
    Wilson VG; Rangasamy D
    Exp Cell Res; 2001 Nov; 271(1):57-65. PubMed ID: 11697882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9.
    Tatham MH; Jaffray E; Vaughan OA; Desterro JM; Botting CH; Naismith JH; Hay RT
    J Biol Chem; 2001 Sep; 276(38):35368-74. PubMed ID: 11451954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SUMO-1 targets RanGAP1 to kinetochores and mitotic spindles.
    Joseph J; Tan SH; Karpova TS; McNally JG; Dasso M
    J Cell Biol; 2002 Feb; 156(4):595-602. PubMed ID: 11854305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting.
    Rodriguez MS; Dargemont C; Hay RT
    J Biol Chem; 2001 Apr; 276(16):12654-9. PubMed ID: 11124955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3.
    Saitoh H; Hinchey J
    J Biol Chem; 2000 Mar; 275(9):6252-8. PubMed ID: 10692421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the ubiquitin carrier proteins, E2s, involved in signal-induced conjugation and subsequent degradation of IkappaBalpha.
    Gonen H; Bercovich B; Orian A; Carrano A; Takizawa C; Yamanaka K; Pagano M; Iwai K; Ciechanover A
    J Biol Chem; 1999 May; 274(21):14823-30. PubMed ID: 10329681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of Daxx, a Fas binding protein, with sentrin and Ubc9.
    Ryu SW; Chae SK; Kim E
    Biochem Biophys Res Commun; 2000 Dec; 279(1):6-10. PubMed ID: 11112409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUMO, ubiquitin's mysterious cousin.
    Müller S; Hoege C; Pyrowolakis G; Jentsch S
    Nat Rev Mol Cell Biol; 2001 Mar; 2(3):202-10. PubMed ID: 11265250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.